Bristol Myers Squibb (BMY) Buildings (2015 - 2026)

Bristol Myers Squibb (BMY) has reported Buildings for 12 consecutive years, with $7.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Buildings rose 15.73% year-over-year to $7.9 billion in Q2 2026; TTM through Jun 2026 was $7.9 billion, a 15.73% increase from a year earlier, with the FY2025 full-year figure at $7.3 billion, up 10.47% from the prior year.
• Buildings was $7.9 billion for Q2 2026 at Bristol Myers Squibb, up from $7.5 billion in the prior quarter.
• Over five years, Buildings peaked at $7.9 billion in Q2 2026 and troughed at $5.7 billion in Q2 2022.
• A 5-year average of $6.5 billion and a median of $6.5 billion in 2023 frame the typical range for Buildings.
• Across the five-year window, Buildings advanced 0.09% in 2022 and climbed 15.73% in 2026, its largest moves.
• Over 5 years, Buildings stood at $5.9 billion in 2022, then grew by 9.71% to $6.5 billion in 2023, then increased by 1.32% to $6.6 billion in 2024, then increased by 10.47% to $7.3 billion in 2025, then gained by 9.12% to $7.9 billion in 2026.
• The last three Buildings figures came in at $7.9 billion (Q2 2026), $7.5 billion (Q1 2026), and $7.3 billion (Q4 2025), per Business Quant data.